BeOne Medicines Ltd. SVP and General Counsel Lee Chan Henry filed a Form 4 on November 9, 2026, disclosing the sale of American Depositary Shares on November 5, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.

Key Highlights

  • Reporting person: Lee Chan Henry, SVP and General Counsel of BeOne Medicines Ltd. (NASDAQ:ONC)
  • First sale: 660 American Depositary Shares (ADS) disposed of on November 5, 2026, at $400 per ADS
  • Second sale: 455 ADS disposed of on November 5, 2026, at $402 per ADS
  • Post-transaction ADS holdings: 0 ADS held directly following the reported transactions
  • Ordinary shares held: 296,829 Ordinary Shares beneficially owned directly (reported separately from ADS)
  • 10b5-1 plan: Both sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2026
  • ADS ratio: Each American Depositary Share represents 13 Ordinary Shares, according to the filing

Lee Chan Henry ADS Sales Under Pre-Arranged Trading Plan

According to the Form 4 filed with the SEC, Lee Chan Henry, who serves as SVP and General Counsel of BeOne Medicines Ltd. (NASDAQ:ONC), reported two dispositions of American Depositary Shares on November 5, 2026. The first transaction involved 660 ADS sold at $400 per share, and the second involved 455 ADS sold at $402 per share. Both transactions carried transaction code "S" and were classified as disposals (D) under the filing's Table I.

The filing notes that each American Depositary Share represents 13 Ordinary Shares. Following the two reported ADS transactions, Henry's direct beneficial ownership of ADS fell to 0. Separately, the filing reports that Henry continues to directly hold 296,829 Ordinary Shares. The filing does not indicate any change to that Ordinary Share position as part of these transactions.

Both sales were carried out under a Rule 10b5-1 trading plan that Henry adopted on May 29, 2026, as stated in the filing's explanation of responses. The Form 4 was signed on November 9, 2026, by Frank Collazo acting as Attorney-in-Fact for the reporting person. The filing indicates that Henry checked the box confirming that transactions were made pursuant to a contract, instruction, or written plan satisfying Rule 10b5-1(c) conditions.

What Was Disclosed

BeOne Medicines SVP and General Counsel Lee Chan Henry disclosed the sale of 1,115 total American Depositary Shares on November 5, 2026, in two tranches at prices of $400 and $402 per ADS, reducing his direct ADS holdings to zero under a pre-established 10b5-1 plan.